CLSI POCT05
Performance Metrics for Continuous Interstitial Glucose Monitoring
active, Most Current
Buy Now
| Organization: | CLSI |
| Publication Date: | 1 November 2020 |
| Status: | active |
| Page Count: | 82 |
scope:
This guideline provides recommendations for methods used to determine analytical and clinical metrics of continuous glucose monitoring (CGM) as an indicator of blood glucose values. It discusses use cases, point accuracy, trend accuracy, evaluation of threshold alerts, system stability and reliability, clinical studies for assessing CGM performance, calibration, traceability of measurement, cybersecurity, and device labeling.
The intended users of this guideline are in vitro diagnostic and medical device manufacturers, regulatory agencies, and health care professionals. This guideline is not intended for use by patients and does not discuss devices that do not meet the definitions of continuous, interstitial, and glucose monitoring.
Document History
CLSI POCT05
November 1, 2020
Performance Metrics for Continuous Interstitial Glucose Monitoring
This guideline provides recommendations for methods used to determine analytical and clinical metrics of continuous glucose monitoring (CGM) as an indicator of blood glucose values. It discusses use...
December 1, 2008
Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline
This guideline specifies requirements/recommendations for methods for determining analytical and clinical metrics of continuous interstitial glucose monitoring. It defines the following aspects of...